vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and N2OFF, Inc. (NITO). Click either name above to swap in a different company.

Bioceres Crop Solutions Corp. is the larger business by last-quarter revenue ($77.6M vs $2.0K, roughly 38798.3× N2OFF, Inc.). N2OFF, Inc. runs the higher net margin — 21450.0% vs -9.6%, a 21459.6% gap on every dollar of revenue. On growth, Bioceres Crop Solutions Corp. posted the faster year-over-year revenue change (-16.8% vs -77.8%). Over the past eight quarters, Bioceres Crop Solutions Corp.'s revenue compounded faster (-8.4% CAGR vs -86.2%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

BIOX vs NITO — Head-to-Head

Bigger by revenue
BIOX
BIOX
38798.3× larger
BIOX
$77.6M
$2.0K
NITO
Growing faster (revenue YoY)
BIOX
BIOX
+61.0% gap
BIOX
-16.8%
-77.8%
NITO
Higher net margin
NITO
NITO
21459.6% more per $
NITO
21450.0%
-9.6%
BIOX
Faster 2-yr revenue CAGR
BIOX
BIOX
Annualised
BIOX
-8.4%
-86.2%
NITO

Income Statement — Q1 2026 vs Q3 2025

Metric
BIOX
BIOX
NITO
NITO
Revenue
$77.6M
$2.0K
Net Profit
$-7.4M
$429.0K
Gross Margin
46.8%
Operating Margin
9.3%
-66300.0%
Net Margin
-9.6%
21450.0%
Revenue YoY
-16.8%
-77.8%
Net Profit YoY
-20.2%
118.9%
EPS (diluted)
$-0.12
$0.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
NITO
NITO
Q3 25
$77.6M
$2.0K
Q2 25
$0
Q1 25
$60.6M
$66.0K
Q4 24
$98.8M
$140.0K
Q3 24
$93.3M
$9.0K
Q2 24
$17.0K
Q1 24
$84.0M
$44.0K
Q4 23
$140.2M
$105.4K
Net Profit
BIOX
BIOX
NITO
NITO
Q3 25
$-7.4M
$429.0K
Q2 25
$-4.5M
Q1 25
$-1.6M
$-1.2M
Q4 24
$605.2K
$-1.4M
Q3 24
$-6.2M
$-2.3M
Q2 24
$-787.0K
Q1 24
$9.8M
$-769.0K
Q4 23
$1.2M
$-1.7M
Gross Margin
BIOX
BIOX
NITO
NITO
Q3 25
46.8%
Q2 25
Q1 25
39.4%
78.8%
Q4 24
42.0%
61.4%
Q3 24
40.2%
-755.6%
Q2 24
64.7%
Q1 24
50.8%
36.4%
Q4 23
36.7%
Operating Margin
BIOX
BIOX
NITO
NITO
Q3 25
9.3%
-66300.0%
Q2 25
Q1 25
1.5%
-937.9%
Q4 24
14.5%
-72.1%
Q3 24
2.5%
-15955.6%
Q2 24
-4982.4%
Q1 24
15.7%
-2043.2%
Q4 23
12.0%
-2028.0%
Net Margin
BIOX
BIOX
NITO
NITO
Q3 25
-9.6%
21450.0%
Q2 25
Q1 25
-2.6%
-1807.6%
Q4 24
0.6%
-980.7%
Q3 24
-6.6%
-25155.6%
Q2 24
-4629.4%
Q1 24
11.6%
-1747.7%
Q4 23
0.9%
-1644.7%
EPS (diluted)
BIOX
BIOX
NITO
NITO
Q3 25
$-0.12
$0.97
Q2 25
$-0.18
Q1 25
$-0.02
$-0.39
Q4 24
$0.00
$-26.86
Q3 24
$-0.10
$-0.39
Q2 24
$-0.23
Q1 24
$0.14
$-0.26
Q4 23
$0.00
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
NITO
NITO
Cash + ST InvestmentsLiquidity on hand
$15.5M
$6.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$288.3M
$8.9M
Total Assets
$734.9M
$11.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
NITO
NITO
Q3 25
$15.5M
$6.3M
Q2 25
$3.4M
Q1 25
$38.5M
$3.0M
Q4 24
$29.2M
$2.2M
Q3 24
$32.3M
$2.7M
Q2 24
$4.5M
Q1 24
$16.4M
$3.5M
Q4 23
$24.4M
$4.4M
Stockholders' Equity
BIOX
BIOX
NITO
NITO
Q3 25
$288.3M
$8.9M
Q2 25
$5.8M
Q1 25
$345.0M
$3.9M
Q4 24
$346.3M
$4.7M
Q3 24
$346.0M
$5.4M
Q2 24
$6.0M
Q1 24
$348.5M
$5.8M
Q4 23
$335.3M
$6.5M
Total Assets
BIOX
BIOX
NITO
NITO
Q3 25
$734.9M
$11.0M
Q2 25
$7.8M
Q1 25
$798.2M
$7.4M
Q4 24
$835.2M
$5.5M
Q3 24
$827.3M
$5.8M
Q2 24
$7.5M
Q1 24
$836.1M
$6.3M
Q4 23
$819.5M
$7.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
NITO
NITO
Operating Cash FlowLast quarter
$14.4M
$-974.0K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
-2.27×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
NITO
NITO
Q3 25
$14.4M
$-974.0K
Q2 25
$-528.0K
Q1 25
$23.3M
$-809.0K
Q4 24
$-5.4M
$-492.0K
Q3 24
$5.2M
$-891.0K
Q2 24
$-1.0M
Q1 24
$-17.4M
$-1.0M
Q4 23
$21.1M
$-975.1K
Cash Conversion
BIOX
BIOX
NITO
NITO
Q3 25
-2.27×
Q2 25
Q1 25
Q4 24
-8.85×
Q3 24
Q2 24
Q1 24
-1.78×
Q4 23
17.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons